VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into AnaptysBio, Inc. (ANAB) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $1.4B · revenue $106M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows